Stock comparison
P3 Health Partners is 1.4x more valuable than GeneDx Holdings Corp. by market capitalization ($2.96 B vs $2.06 B). Compare market value, revenue, profit, margins, filings, and source pages in one place.
Quick answer
PIII is larger
P3 Health Partners is 1.4x more valuable than GeneDx Holdings Corp. by market capitalization ($2.96 B vs $2.06 B).
Market value leader
PIII
P3 Health Partners is 1.4x more valuable than GeneDx Holdings Corp. by market capitalization ($2.96 B vs $2.06 B).
Revenue leader
PIII
PIII: $1.46B vs WGS: $427.54M.
Profit leader
WGS
PIII: -$147.95M vs WGS: -$21.00M.
Margin leader
WGS
PIII: -10.1% vs WGS: -4.9% net margin.
| Metric | PIII | WGS |
|---|---|---|
| Market cap | $2.96 B | $2.06 B |
| US-listed rank | #1834 | #2118 |
| Revenue (latest FY) | $1.46B | $427.54M |
| Net income (latest FY) | -$147.95M | -$21.00M |
| Net margin | -10.1% | -4.9% |
| P/E (trailing FY) | - | - |
| SEC filings | 387 | 748 |
Jump from this comparison into the underlying pages for market value, annual fundamentals, and company filing history.
Market cap uses refreshed market data. Revenue, net income, margins, and trailing fiscal-year P/E use annual company facts from filings. If a metric is missing, the source data did not have a clean recent annual value for that company.
P3 Health Partners is 1.4x more valuable than GeneDx Holdings Corp. by market capitalization ($2.96 B vs $2.06 B).
In their latest fiscal years, P3 Health Partners reported $1.46B in revenue while GeneDx Holdings Corp. reported $427.54M.
Full pages: P3 Health Partners and GeneDx Holdings Corp., or browse the full rankings.